Peng‐Hui Wang

机构：National Yang Ming Chiao Tung University, China Medical University, Taipei Veterans General Hospital, China Medical University Hospital, Koo Foundation Sun Yat-Sen Cancer Center · ORCID：0000-0002-6048-8541

发表论文 790 篇 · 总被引 12721 次 · h-index 54

代表论文

• Programmed death-ligand 1 upregulation is associated with poor prognosis in patients with epithelial ovarian cancer (2025 · Journal of the Chinese Medical Association · 被引 16)
• Antibody-drug conjugates (ADCs) may be a big breakthrough in gynecologic cancer treatment (III): Understanding of ADC (2025 · Taiwanese Journal of Obstetrics and Gynecology · 被引 8)
• Targeted biomarkers of antibody–drug conjugates (ADCs) (2025 · Taiwanese Journal of Obstetrics and Gynecology · 被引 7)
• Endometrial cancer: Mismatch repair proficient (MMRp) with TP53 protein mutations (2025 · Taiwanese Journal of Obstetrics and Gynecology · 被引 7)
• Immunology and therapeutic strategies in ovarian cancer (2026 · Taiwanese Journal of Obstetrics and Gynecology · 被引 5)
• A challenge for treating patients with extensive-stage small cell lung cancers, particularly for those with liver metastases (2025 · Journal of the Chinese Medical Association · 被引 4)